Literature DB >> 7962345

Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure.

L M Nelson1, J N Anasti, L M Kimzey, R A Defensor, K J Lipetz, B J White, T H Shawker, M J Merino.   

Abstract

Despite having amenorrhea and markedly elevated serum gonadotropin levels, some women with karyotypically normal spontaneous premature ovarian failure, nevertheless, have ovarian follicles that function intermittently. Graafian follicles capable of responding to these high FSH levels are faced with high serum LH levels as well, which might induce inappropriate luteinization and prevent normal follicle function. We examined this possibility using weekly blood sampling and sonography in 65 patients. Nearly 50% of our patients demonstrated ovarian follicle function [serum estradiol, > 183 pmol/L (50 pg/mL)] during a median of 4 months of observation (range, 2-6 months). However, during this observation, only 16% achieved an ovulatory serum progesterone level [> 9.5 nmol/L (3.0 ng/mL)]. We imaged an antral follicle by sonography in over 40% of patients (27 of 65), and serum estradiol was significantly greater when an antral follicle was present. The follicles in these patients were not functioning normally, however. In contrast to normal women, patients with ovarian failure had poor correlation between follicle diameter and serum estradiol. We biopsied these antral follicles in 6 patients and found luteinized Graafian follicles in all cases. Therefore, luteinized Graafian follicles account for at least 60% of the antral structures imaged (95% confidence limit). Thus, inappropriate luteinization of Graafian follicles appears to be a major pathophysiological mechanism in patients with karyotypically normal spontaneous premature ovarian failure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962345     DOI: 10.1210/jcem.79.5.7962345

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

Review 1.  Ovarian reserve evaluation: state of the art.

Authors:  Bruno Ramalho de Carvalho; Ana Carolina Japur de Sá Rosa e Silva; Júlio César Rosa e Silva; Rosana Maria dos Reis; Rui Alberto Ferriani; Marcos Felipe Silva de Sá
Journal:  J Assist Reprod Genet       Date:  2008-08-05       Impact factor: 3.412

2.  Impaired production of BMP-15 and GDF-9 mature proteins derived from proproteins WITH mutations in the proregion.

Authors:  Kenichi Inagaki; Shunichi Shimasaki
Journal:  Mol Cell Endocrinol       Date:  2010-06-12       Impact factor: 4.102

3.  The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.

Authors:  Queenie Ho Yan Wong; Tracy Wing Yee Yeung; Sofie Shuk Fei Yung; Jennifer Ka Yee Ko; Hang Wun Raymond Li; Ernest Hung Yu Ng
Journal:  J Assist Reprod Genet       Date:  2018-03-09       Impact factor: 3.412

Review 4.  Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency.

Authors:  Jenny A Visser; Izaäk Schipper; Joop S E Laven; Axel P N Themmen
Journal:  Nat Rev Endocrinol       Date:  2012-01-10       Impact factor: 43.330

5.  Very Low Levels of Serum Anti-Müllerian Hormone as a Possible Marker for Follicle Growth in Patients with Primary Ovarian Insufficiency Under Hormone Replacement Therapy.

Authors:  Yukiyo Kasahara; Satoko Osuka; Natsuki Nakanishi; Tomohiko Murase; Tomoko Nakamura; Maki Goto; Tomomi Kotani; Akira Iwase; Fumitaka Kikkawa
Journal:  Reprod Sci       Date:  2020-07-31       Impact factor: 3.060

6.  A prospective evaluation of antral follicle function in women with 46,XX spontaneous primary ovarian insufficiency.

Authors:  Ziad R Hubayter; Vaishali Popat; Vien H Vanderhoof; Obioma Ndubizu; Diane Johnson; Edie Mao; Karim A Calis; James F Troendle; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2009-11-25       Impact factor: 7.329

7.  Screening of follicle-stimulating hormone receptor gene in women with premature ovarian failure in southern Brazil and associations with phenotype.

Authors:  L C Vilodre; M B F Kohek; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

8.  A randomized controlled study of a consent intervention for participating in an NIH genome sequencing study.

Authors:  Erin Turbitt; Paola P Chrysostomou; Holly L Peay; Alexis R Heidlebaugh; Lawrence M Nelson; Barbara B Biesecker
Journal:  Eur J Hum Genet       Date:  2018-02-16       Impact factor: 4.246

Review 9.  Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR.

Authors:  Lisa M Pastore; Mindy S Christianson; James Stelling; William G Kearns; James H Segars
Journal:  J Assist Reprod Genet       Date:  2017-10-02       Impact factor: 3.412

10.  The psychosocial transition associated with spontaneous 46,XX primary ovarian insufficiency: illness uncertainty, stigma, goal flexibility, and purpose in life as factors in emotional health.

Authors:  Mary Davis; June L Ventura; Mary Wieners; Sharon N Covington; Vien H Vanderhoof; Mary E Ryan; Deloris E Koziol; Vaishali B Popat; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2009-02-24       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.